Morphea Clinical Trial
Official title:
Immunologic and Genetic Profiles in Subsets of Morphea Patients
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: - How morphea behaves over time - How frequently specific problems occur along with morphea (for example, arthritis) - Whether morphea has an autoimmune background
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03351114 -
Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea
|
Phase 2 | |
| Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
| Withdrawn |
NCT00230373 -
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
|
Phase 3 | |
| Completed |
NCT01799174 -
Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
|
N/A | |
| Terminated |
NCT02411643 -
Molecular Effects of Topical Calcipotriene on Morphea
|
Early Phase 1 | |
| Enrolling by invitation |
NCT04922736 -
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
|
N/A | |
| Withdrawn |
NCT04656704 -
Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease
|
Early Phase 1 | |
| Completed |
NCT04752397 -
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
|
||
| Terminated |
NCT03740724 -
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
|
Phase 1/Phase 2 | |
| Completed |
NCT02222038 -
Genetic Variants in Linear Localized Scleroderma
|
N/A |